swiss national startup team venture leaders biotech
TRANSCRIPT
DATA 1
DATA 2
DATA 3
DATA 4
2 0 1 32 0 1 4
2 0 1 52 0 1 6
2 0 1 72 0 1 8
2 0 1 92 0 2 0
Meet industry leaders and international biotech investors on an exclusive roadshow
Swiss National Startup Team
Win your place in the Swiss National Startup
Team 2021
Apply by June 6, 2021 www.venture-leaders.ch/biotech
Venture Leaders Biotech
Organized by: Supported by:
August 12, 2021Kick-o� event presenting the Venture Leaders, including a pitching session
October 18-24, 2021Dive into the global entrepreneurial scene and personal development
Late 2021Graduation ceremony in Switzerland
Stefanie Flückiger-Mangual, Co-Founder and CEO,
TOLREMO therapeutics
“Venture Leaders was a fantastic program that allowed me to expand
my professional network to the venture capital ecosystem!”
June 6, 2021Final date for submission of applications
June 24, 2021Personal presentation by the best20 applicants in front of the jury
Program for the 10 winners
Venture Leaders have a clear-cut goal. They envision themselves as global players and want to take the first step towards their global expansion.
The investor and business development roadshow to hotspots for biotech innovation allows for a deep-dive into the global startup scene and includes public and private pitch sessions, high-level networking opportunities, company visits and individual business development activities.
Venture Leaders Biotech is co-organized by Venturelab and Swissnex in China. The program with a value of CHF 10,000 is o�ered free of charge to the winner's thanks to the support of EPF Lausanne, ETH Zurich, VISCHER and the Canton of Zurich.
Admission ProcessThose eligible to participate are:
— Founding and managing members of Swiss biotech startups;
— Fundraising and ready to grow business with international investors;
— Building a global biotech startup.
Any questions? [email protected] +41 (0)71 242 98 88 www.venture-leaders.ch/biotech
Apply by June 6, 2021
“Venture Leaders is a one of a kind program,
helping me reach out to potential investors and
business partners in mainland China, Hong
Kong and Asia.” Rajwinder Lehal, Chief Scientific O�icer,
Cellestia Biotech